vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and LEGGETT & PLATT INC (LEG). Click either name above to swap in a different company.

LEGGETT & PLATT INC is the larger business by last-quarter revenue ($938.6M vs $487.7M, roughly 1.9× CLOVER HEALTH INVESTMENTS, CORP.). LEGGETT & PLATT INC runs the higher net margin — 2.7% vs -10.1%, a 12.8% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs -11.2%). LEGGETT & PLATT INC produced more free cash flow last quarter ($101.9M vs $-69.0M). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (18.6% CAGR vs -7.5%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

Leggett & Platt (L&P), based in Carthage, Missouri, is an American diversified manufacturer that designs and produces various engineered components and products that can be found in homes and automobiles. The firm was founded in 1883, and consists of 15 business units, 20,000 employee-partners, and 135 manufacturing facilities located in 18 countries.

CLOV vs LEG — Head-to-Head

Bigger by revenue
LEG
LEG
1.9× larger
LEG
$938.6M
$487.7M
CLOV
Growing faster (revenue YoY)
CLOV
CLOV
+55.9% gap
CLOV
44.7%
-11.2%
LEG
Higher net margin
LEG
LEG
12.8% more per $
LEG
2.7%
-10.1%
CLOV
More free cash flow
LEG
LEG
$170.9M more FCF
LEG
$101.9M
$-69.0M
CLOV
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
18.6%
-7.5%
LEG

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CLOV
CLOV
LEG
LEG
Revenue
$487.7M
$938.6M
Net Profit
$-49.3M
$25.1M
Gross Margin
17.9%
Operating Margin
-10.1%
2.0%
Net Margin
-10.1%
2.7%
Revenue YoY
44.7%
-11.2%
Net Profit YoY
-123.2%
76.8%
EPS (diluted)
$0.18

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
LEG
LEG
Q4 25
$487.7M
$938.6M
Q3 25
$496.6M
$1.0B
Q2 25
$477.6M
$1.1B
Q1 25
$462.3M
$1.0B
Q4 24
$337.0M
$1.1B
Q3 24
$331.0M
$1.1B
Q2 24
$356.3M
$1.1B
Q1 24
$346.9M
$1.1B
Net Profit
CLOV
CLOV
LEG
LEG
Q4 25
$-49.3M
$25.1M
Q3 25
$-24.4M
$127.1M
Q2 25
$-10.6M
$52.5M
Q1 25
$-1.3M
$30.6M
Q4 24
$-22.1M
$14.2M
Q3 24
$-9.2M
$44.9M
Q2 24
$7.4M
$-602.2M
Q1 24
$-19.2M
$31.6M
Gross Margin
CLOV
CLOV
LEG
LEG
Q4 25
17.9%
Q3 25
18.7%
Q2 25
18.2%
Q1 25
18.6%
Q4 24
16.6%
Q3 24
24.5%
18.2%
Q2 24
30.3%
16.5%
Q1 24
23.6%
17.0%
Operating Margin
CLOV
CLOV
LEG
LEG
Q4 25
-10.1%
2.0%
Q3 25
-4.9%
14.9%
Q2 25
-2.2%
6.8%
Q1 25
-0.3%
4.4%
Q4 24
-6.4%
2.4%
Q3 24
-2.7%
5.2%
Q2 24
2.0%
-56.2%
Q1 24
-6.5%
3.9%
Net Margin
CLOV
CLOV
LEG
LEG
Q4 25
-10.1%
2.7%
Q3 25
-4.9%
12.3%
Q2 25
-2.2%
5.0%
Q1 25
-0.3%
3.0%
Q4 24
-6.6%
1.3%
Q3 24
-2.8%
4.1%
Q2 24
2.1%
-53.4%
Q1 24
-5.5%
2.9%
EPS (diluted)
CLOV
CLOV
LEG
LEG
Q4 25
$0.18
Q3 25
$0.91
Q2 25
$0.38
Q1 25
$0.22
Q4 24
$0.10
Q3 24
$0.33
Q2 24
$-4.39
Q1 24
$0.23

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
LEG
LEG
Cash + ST InvestmentsLiquidity on hand
$78.3M
$587.4M
Total DebtLower is stronger
$1.5B
Stockholders' EquityBook value
$308.7M
$1.0B
Total Assets
$541.0M
$3.5B
Debt / EquityLower = less leverage
1.46×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
LEG
LEG
Q4 25
$78.3M
$587.4M
Q3 25
$460.7M
Q2 25
$368.8M
Q1 25
$412.6M
Q4 24
$194.5M
$350.2M
Q3 24
$288.0M
$277.2M
Q2 24
$254.8M
$307.0M
Q1 24
$208.3M
$361.3M
Total Debt
CLOV
CLOV
LEG
LEG
Q4 25
$1.5B
Q3 25
$1.5B
Q2 25
$1.8B
Q1 25
$1.9B
Q4 24
$1.9B
Q3 24
$1.6B
Q2 24
$1.7B
Q1 24
$1.8B
Stockholders' Equity
CLOV
CLOV
LEG
LEG
Q4 25
$308.7M
$1.0B
Q3 25
$340.9M
$971.8M
Q2 25
$344.2M
$855.0M
Q1 25
$336.1M
$746.8M
Q4 24
$341.1M
$689.4M
Q3 24
$342.2M
$741.0M
Q2 24
$324.9M
$667.6M
Q1 24
$292.5M
$1.3B
Total Assets
CLOV
CLOV
LEG
LEG
Q4 25
$541.0M
$3.5B
Q3 25
$559.7M
$3.5B
Q2 25
$575.0M
$3.7B
Q1 25
$583.7M
$3.7B
Q4 24
$580.7M
$3.7B
Q3 24
$653.0M
$3.8B
Q2 24
$674.2M
$3.8B
Q1 24
$671.8M
$4.6B
Debt / Equity
CLOV
CLOV
LEG
LEG
Q4 25
1.46×
Q3 25
1.54×
Q2 25
2.10×
Q1 25
2.59×
Q4 24
2.70×
Q3 24
2.13×
Q2 24
2.55×
Q1 24
1.38×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
LEG
LEG
Operating Cash FlowLast quarter
$-66.9M
$121.5M
Free Cash FlowOCF − Capex
$-69.0M
$101.9M
FCF MarginFCF / Revenue
-14.1%
10.9%
Capex IntensityCapex / Revenue
0.4%
2.1%
Cash ConversionOCF / Net Profit
4.84×
TTM Free Cash FlowTrailing 4 quarters
$-69.2M
$281.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
LEG
LEG
Q4 25
$-66.9M
$121.5M
Q3 25
$12.1M
$125.9M
Q2 25
$5.4M
$84.0M
Q1 25
$-16.3M
$6.8M
Q4 24
$34.8M
$122.3M
Q3 24
$50.0M
$95.5M
Q2 24
$44.8M
$94.0M
Q1 24
$25.9M
$-6.1M
Free Cash Flow
CLOV
CLOV
LEG
LEG
Q4 25
$-69.0M
$101.9M
Q3 25
$11.4M
$110.1M
Q2 25
$4.8M
$75.5M
Q1 25
$-16.5M
$-6.5M
Q4 24
$33.3M
$100.5M
Q3 24
$49.6M
$77.1M
Q2 24
$44.4M
$78.5M
Q1 24
$25.5M
$-32.0M
FCF Margin
CLOV
CLOV
LEG
LEG
Q4 25
-14.1%
10.9%
Q3 25
2.3%
10.6%
Q2 25
1.0%
7.1%
Q1 25
-3.6%
-0.6%
Q4 24
9.9%
9.5%
Q3 24
15.0%
7.0%
Q2 24
12.5%
7.0%
Q1 24
7.3%
-2.9%
Capex Intensity
CLOV
CLOV
LEG
LEG
Q4 25
0.4%
2.1%
Q3 25
0.1%
1.5%
Q2 25
0.1%
0.8%
Q1 25
0.0%
1.3%
Q4 24
0.5%
2.1%
Q3 24
0.1%
1.7%
Q2 24
0.1%
1.4%
Q1 24
0.1%
2.4%
Cash Conversion
CLOV
CLOV
LEG
LEG
Q4 25
4.84×
Q3 25
0.99×
Q2 25
1.60×
Q1 25
0.22×
Q4 24
8.61×
Q3 24
2.13×
Q2 24
6.04×
Q1 24
-0.19×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLOV
CLOV

Segment breakdown not available.

LEG
LEG

Bedding Products$373.8M40%
Flooring And Textile Products Group$196.9M21%
Automotive Group$194.9M21%
Work Furniture Group$66.2M7%
Home Furniture Group$61.0M6%
Hydraulic Cylinders$45.8M5%

Related Comparisons